Published: Apr, 2019

The demand within the global market for vaccines has been rising on account of advancements in the field of medical therapy and disease prevention, finds Transparency Market Research (TMR). There is a high probability of new vendors emerging in the global vaccines market in the years to come. The historic trends have been suggestive of the opportunities that have aided market growth in recent times. The leading vendors in the global vaccines market have engaged in core research and development in order to earn increased revenues. Furthermore, these vendors are projected to invest in new vaccination lines to elevate their standards of production.

The competition in the global market for vaccines is expected to intensify in the years to come. This is because a large number of established players are moving neck and neck in the quest to develop more effective vaccines. The competition in the global vaccines market has further escalated on account of the emergence of newbie vendors in the global vaccines market. There is a heavy possibility of strategic alliances being formed in the global vaccines market. Some of the key players in the global vaccines market are CSL Ltd, Janssen Pharmaceutical Company, GlaxoSmithKline plc., Pfizer, Inc., Mitsubishi Tanabe Pharma Corporation, and Sanofi Pasteur SA.

Transparency Market Research (TMR) predicts that the global market for vaccines would expand at a healthy CAGR of 6.0% over the period between 2017 and 2025. Furthermore, the cumulative value of the global vaccines market is projected to reach US$ 48.0 Bn by 2025-end, rising up from a value of US$ 28.0 Bn in 2016. On the basis of vaccine type, the market for toxoid vaccines is expected to expand in the years to come. Based on geography, the market for vaccines in Europe is projected to accumulate humongous revenues in the years to come.
global vaccines market

Request a PDF Sample https://www.transparencymarketresearch.com/sample/sample.php?flag=S&rep_id=21

Availability of Vaccines for Kids to Propels

The global market for vaccines caters to the masses of all age groups, including children. The need to vaccinate children in order to prevent them from serious diseases is being felt across the world. Hence, the global vaccines market is projected to expand alongside advancements in the field of disease care and paediatrics. Furthermore, the market for vaccines has also expanded on account of the growth of new and advanced facilities across medical facilities such as healthcare centers and hospitals. Doctors and medical practitioners recommend all essential vaccines for people of various age groups which in turn pushes market growth.

Emergence of New Selling Points to Aid Market Growth

The global market for vaccines has been expanding alongside increase in the number of distribution channels for vaccines. The popularity of institutional sales for the purposeof vaccination has created stellar opportunities for growth within the global market. Moreover, hospitals now have dedicated sections for vaccination and treatment which has in turn propelled market demand. Medication and injective vaccines are also available across retail pharmacies, and this another key consideration from the perspective of market growth. The revenue index of the global vaccines market is projected to reach new volumes in the years to come.

The review is based on TMR’s report titled, “Vaccines Market (Vaccine Type - Inactivated, Live Attenuated, Toxoid, Conjugate; Valance - Monovalent, Multivalent; Route of Administration - Oral, Injectable; Indication - Influenza, Hepatitis, Polio, Meningococcal Disease, Pneumococcal Disease, DTP, Rotavirus, MMR, Human Papilloma Virus; Distribution Channel - Institutional Sales, Hospital Pharmacies, Retail Pharmacies) - Global Industry Analysis, Size, Share, Growth, Trends, and Forecast 2017 – 2025”.

The global vaccines market has been segmented as presented:

By Vaccine Type:

  • Inactivated
  • Live Attenuated
  • Toxoid
  • Conjugate

By Valance:

  • Monovalent
  • Multivalent

By Route of Administration:

  • Oral
  • Injectable

By Indication:

  • Influenza
  • Hepatitis
  • Polio
  • Meningococcal Disease
  • Pneumococcal Disease
  • DTP
  • Rotavirus
  • MMR
  • Human Papilloma Virus

By Distribution Channel:

  • Institutional Sales
  • Hospital Pharmacies
  • Retail Pharmacies

By Region:

  • North America
    • U.S.
    • Canada
  • Europe
    • U.K.
    • Germany
    • France
    • Spain
    • Italy
    • Rest of Europe
  • Asia Pacific
    • India
    • China
    • Japan
    • Rest of Asia Pacific
  • Latin America
    • Brazil
    • Mexico
    • Rest of Latin America
  • Middle East & Africa
    • South Africa
    • GCC countries
    • Rest of MEA

About Us

Transparency Market Research is a next-generation market intelligence provider, offering fact-based solutions to business leaders, consultants, and strategy professionals.

Our reports are single-point solutions for businesses to grow, evolve, and mature. Our real-time data collection methods along with ability to track more than one million high growth niche products are aligned with your aims. The detailed and proprietary statistical models used by our analysts offer insights for making right decision in the shortest span of time. For organizations that require specific but comprehensive information we offer customized solutions through adhoc reports. These requests are delivered with the perfect combination of right sense of fact-oriented problem solving methodologies and leveraging existing data repositories.

TMR believes that unison of solutions for clients-specific problems with right methodology of research is the key to help enterprises reach right decision.

Contact Us

Transparency Market Research
State Tower,
90 State Street,
Suite 700,
Albany NY - 12207
United States
USA - Canada Toll Free: 866-552-3453
Email: sales@transparencymarketresearch.com
Website: https://www.transparencymarketresearch.co